|
🐜
|
Systematic review of the influence of chemotherapy‐associated liver injury on outcome after partial hepatectomy for colorectal liver metastases
31 auth.
J. Zhao,
K. V. van Mierlo,
J. Gómez-Ramírez,
H. Kim,
C. H. C. Pilgrim,
P. Pessaux,
S. Rensen,
E. P. van der Stok,
F. G. Schaap,
O. Soubrane,
T. Takamoto,
L. Viganò,
B. Winkens,
C. C. Dejong,
S. Olde Damink,
...
I. García Sánz,
E. Martín Pérez,
J. Y. Cho,
Y. R. Choi,
W. Phillips,
M. Michael,
F. Panaro,
M.‐P. Chenard,
C. Verhoef,
D. Grünhagen,
J. Vara,
O. Scatton,
T. Hashimoto,
M. Makuuchi,
G. De Rosa,
N. Ravarino
|
6 |
2017 |
6
🐜
|
|
🐢
|
Feasibility of randomized controlled trials in liver surgery using surgery‐related mortality or morbidity as endpoint
M. A. J. van den Broek,
R. Van Dam,
M. Malágo,
C. Dejong,
G. van Breukelen,
S. Olde Damink
|
5 |
2009 |
5
🐢
|
|
🐢
|
Development of a composite endpoint for randomized controlled trials in liver surgery
9 auth.
M. A. J. van den Broek,
R. Van Dam,
G. van Breukelen,
M. Bemelmans,
E. Oussoultzoglou,
P. Pessaux,
...
C. Dejong,
N. Freemantle,
S. Olde Damink
|
5 |
2011 |
5
🐢
|
|
🐜
|
Delivery of hepato-pancreato-biliary surgery during the COVID-19 pandemic: an European-African Hepato-Pancreato-Biliary Association (E-AHPBA) cross-sectional survey
20 auth.
A. Balakrishnan,
M. Lesurtel,
A. Siriwardena,
S. Heinrich,
A. Serrablo,
M. Besselink,
M. Erkan,
B. Andersson,
W. Polak,
A. Laurenzi,
...
S. Olde Damink,
F. Berrevoet,
Isabella Frigerio,
J. Ramia,
T. Gallagher,
S. Warner,
S. Shrikhande,
R. Adam,
M. Smith,
K. Conlon
|
5 |
2020 |
5
🐜
|
|
🐬
|
Unusual Nosocomial Transmission of Mycobacterium tuberculosis
J. Keijman,
J. Tjhie,
S. Olde Damink,
M. Alink
|
3 |
2001 |
3
🐬
|
|
🐜
|
The orange-III study: the use of preoperative laxatives prior to liver surgery in an enhanced recovery programme, a randomized controlled trial.
11 auth.
V. van Woerden,
B. Olij,
R. Fichtinger,
T. Lodewick,
M. Coolsen,
M. den Dulk,
...
D. Heise,
S. Olde Damink,
C. Dejong,
U. Neumann,
R. V. van Dam
|
0 |
2022 |
0
🐜
|
|
🐢
|
The CHOP Study – Cholestatic Influence on Portal Vein Embolization (PVE) Induced Future Liver Remnant (FLR) Hypertrophy – A Maastricht Aachen Analysis
10 auth.
R. Korenblik,
X. Chang,
B. Olij,
R. Knapen,
C. van der Leij,
D. Heise,
...
U. Neumann,
F. Schaap,
R. Van Dam,
S. Olde Damink
|
0 |
2021 |
0
🐢
|
